Table 4 Perioperative profiles of anesthesia and surgery.
Variable | Control group (n = 41) | TAP + LMA group (n = 42) | P-value |
|---|---|---|---|
Blood lactate (mmol/L) | |||
t0 | 0.9 ± 0.2 | 0.9 ± 0.3 | 0.829 |
t1 | 0.9 ± 0.2 | 1.0 ± 0.2 | 0.180 |
t2 | 2.1 ± 0.5 | 1.6 ± 0.4 | 0.000 |
t3 | 1.5 ± 0.4 | 1.1 ± 0.2 | 0.000 |
Blood glucose (mmol/L) | |||
t0 | 5.1 ± 0.5 | 4.9 ± 0.6 | 0.068 |
t1 | 5.5 ± 0.5 | 5.2 ± 0.2 | 0.039 |
t2 | 8.4 ± 0.8 | 7.8 ± 0.7 | 0.001 |
t3 | 7.4 ± 1.0 | 7.1 ± 0.8 | 0.080 |
Anesthetic requirements | |||
Sevoflurane (ml) | 54.6 ± 9.4 | 39.3 ± 6.5 | 0.000 |
Remifentanil (µg) | 1625.4 ± 264.8 | 1,072.9 ± 190.4 | 0.000 |
Cis-atracurium (mg) | 35.8 ± 4.5 | 21.5 ± 3.7 | 0.000 |
Requirements of vasoactive drugs | |||
Nitroglycerin (mg) | 2.8 ± 0.6 | 2.7 ± 0.7 | 0.467 |
Dobutamine (mg) | 11.2 ± 2.8 | 9.6 ± 2.4 | 0.006 |
Norepinephrine (µg) | 1,203.7 ± 191.1 | 864.5 ± 108.8 | 0.000 |
Duration of anethesia (min) | 268.3 ± 33.5 | 255.9 ± 35.3 | 0.103 |
Duration of operation (min) | 222.8 ± 32.2 | 209.3 ± 35.2 | 0.073 |
Duration of hepatectomy (min) | 122.9 ± 18.2 | 114.4 ± 15.4 | 0.023 |
Duration of hepatic blood flow occlusion (min) | 26.5 ± 5.2 | 21.5 ± 3.5 | 0.000 |
Bleeding volume (ml) | 480.5 ± 90.7 | 395.2 ± 68.8 | 0.000 |
Infusion volume (ml) | 1839.0 ± 374.8 | 1631.0 ± 215.8 | 0.003 |
Urine volume (ml) | 414.6 ± 86.8 | 500.0 ± 96.9 | 0.000 |
Time to removing ETT or LMA (min) | 32.8 ± 4.5 | 19.3 ± 3.9 | 0.000 |
PACU stay (min) | 114.0 ± 14.2 | 95.6 ± 11.4 | 0.000 |
